Filing Details

Accession Number:
0001209191-21-046787
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-07-15 16:48:01
Reporting Period:
2021-07-13
Accepted Time:
2021-07-15 16:48:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1322505 Albireo Pharma Inc. ALBO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1443705 N.r. Simon Harford C/O Albireo Pharma, Inc.
10 Post Office Square, Suite 1000
Boston MA 02109
Cfo And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-07-13 98 $35.02 12,707 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  2. Represents 5,644 shares of common stock and 7,063 restricted stock units. Includes 609 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021.